Thrombosis research · 2013
Coronary Microvascular function, Peripheral Endothelial Function and Carotid IMT in beta-thalassemia minor.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gullu Hakan, Caliskan Mustafa, Caliskan Zuhal, Unler Gulhan Kanat, Ermisler Eda, Ciftci Ozgur, Guven Aytekin, Muderrisoglu Haldun
Аннотация
UNLABELLED: Higher prevalence of cardiovascular disease in Thalassemia patients have been known. Potential mechanisms are enhanced platelet activation, LDL oxidation, macrophage activation, and increased nitric oxide destruction. We have investigated coronary flow reserve (CFR), brachial artery flow mediated dilation (FMD) and Carotid intima-media thickness (IMT) in patients with Beta thalessemia minor (BTM).
METHODS: Forty patients with BTM and 35 healthy control subjects were included. In all subjects CFR, brachial artery FMD, carotid artery IMT were measured.
RESULTS: CFR measurements: Coronary baseline diastolic peak flow velocity (DPFV) of left anterior descending coronary artery (LAD) was significantly higher in the BTM group (23.8 ± 3.9 vs. 22.1 ± 3.0, P = 0.04). However, hyperemic DPFV was significantly lower (61.1 ± 13.0 vs. 68.2 ± 14.2, P = 0.02), and CFR was significantly lower (2.57 ± 0.46 vs. 3.07 ± 0.48, P < 0.0001) in the BTM group than that in the control group. Brachial artery FMD and carotid IMT measurements: Percent FMD measurements were significantly lower in the BTM group than that in the controls (6.22 ± 4.29 vs. 8.10 ± 4.00, P = 0.01). Carotid IMT measurements were significantly but slightly higher in the BTM group than that in the controls (0.57 ± 0.07 vs. 0.54 ± 0.04, P = 0.04).
CONCLUSION: CFR reflecting coronary microvascular function and brachial artery FMD are decreased, and carotid IMT is increased in patients with BTM.
METHODS: Forty patients with BTM and 35 healthy control subjects were included. In all subjects CFR, brachial artery FMD, carotid artery IMT were measured.
RESULTS: CFR measurements: Coronary baseline diastolic peak flow velocity (DPFV) of left anterior descending coronary artery (LAD) was significantly higher in the BTM group (23.8 ± 3.9 vs. 22.1 ± 3.0, P = 0.04). However, hyperemic DPFV was significantly lower (61.1 ± 13.0 vs. 68.2 ± 14.2, P = 0.02), and CFR was significantly lower (2.57 ± 0.46 vs. 3.07 ± 0.48, P < 0.0001) in the BTM group than that in the control group. Brachial artery FMD and carotid IMT measurements: Percent FMD measurements were significantly lower in the BTM group than that in the controls (6.22 ± 4.29 vs. 8.10 ± 4.00, P = 0.01). Carotid IMT measurements were significantly but slightly higher in the BTM group than that in the controls (0.57 ± 0.07 vs. 0.54 ± 0.04, P = 0.04).
CONCLUSION: CFR reflecting coronary microvascular function and brachial artery FMD are decreased, and carotid IMT is increased in patients with BTM.